West Pharmaceutical Services has entered a definitive agreement to divest the manufacturing and supply rights of its SmartDose 3.5mL On-Body Delivery System to AbbVie, as part of a strategic portfolio review, with the transaction expected to close in mid-2026.
West Pharmaceutical Services | 13/01/2026 | By News Bureau | 204
West Pharma Unveils Daikyo PLASCAP RUV Closures in New Nested Format at Pharmapack
This marks West's latest product offering supporting the needs of advanced therapies, one of the fastest growing areas, driven by continued innovation in cell and gene therapy treatments.
West Pharmaceutical Services | 03/02/2025 | By Aishwarya | 360
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy